Another TGF-beta acquisition- bode well for $OTLC/
Post# of 48
(Total Views: 237)
Posted On: 11/10/2021 5:47:11 PM
Another TGF-beta acquisition- bode well for $OTLC/ OT-101 TGF beta inhibitor
https://www.thepharmaletter.com/article/agoma...-origo-buy
“TGF-β is a validated pathway known to be a master regulator of fibrogenesis. Leveraging their advanced small molecule expertise, the Origo team has done an amazing job developing organ-restricted TGF-β approaches, which circumvent toxicity concerns associated with systemic TGF-β blockade.”
https://www.thepharmaletter.com/article/agoma...-origo-buy
“TGF-β is a validated pathway known to be a master regulator of fibrogenesis. Leveraging their advanced small molecule expertise, the Origo team has done an amazing job developing organ-restricted TGF-β approaches, which circumvent toxicity concerns associated with systemic TGF-β blockade.”
(0)
(0)Oncotelic Therapeutics Inc. (OTLC) Stock Research Links
Scroll down for more posts ▼